Cinclus Pharma

About:

Cinclus Pharma is a research based biotech company.

Website: http://www.cincluspharma.com/

Top Investors: Trill Impact, Irrus Investments, Fjarde AP-fonden, Linc, EIR Ventures

Description:

Cinclus Pharma is a research based biotech company developing small molecules for the treatment of gastric acid related diseases. Their main asset, X842, has been studied in a Phase I clinical trial. Cinclus Pharma is based in Basel, Switzerland.

Total Funding Amount:

490M SEK

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Mölndal, Vastra Gotaland, Sweden

Founded Date:

2014-01-01

Founders:

Hansson Lennart, Kjell Andersson, Marek Poszepczynski, Mikael Dahlström, Peter Unge, Urban Paulsson

Number of Employees:

11-50

Last Funding Date:

2022-05-20

IPO Status:

Public

Industries: